Precision Medicine
Dr. Adrienne Boissy, Qualtrics' chief medical officer and staff neurologist at the Cleveland Clinic, explains that, because consumers are making value-based decisions and care about privacy, they should be codesigning healthcare AI.
J29 supports the "HIMSS Gives Back" initiative and has public and private partnerships central to its mission. J29 president and founder Tracy Mills and VP of HHS Programs Nick Vass offer a deep dive.
In a preview of his HIMSS23 presentation, Dr. Cecil Lynch, chief medical information officer at Accenture, describes the current role of genomics in healthcare and discusses how to ensure innovations are more widely used to ensure value-based care.
The technology offers opportunities for care delivery and drug development, says Mohamad Takwa, CEO of Epigenica, a Swedish company that focuses on epigenetic profiling.
The chief information officer of NGS offers predictions for 2023 and beyond: human-centered design, AI and automation, enhanced interoperability, using data to close gaps in care, precision medicine advancements and more.
Wolfgang Mertz, CTO for Unstructured Data Solutions, says Dell Technologies is helping healthcare providers consolidate data – which enables easy access to precision medicine and supports cyber protection strategies.
Translational Research Institute for Space Health Chief Innovation Officer James Hury discusses collaboration and partnership opportunities, and highlights the group's programs that are most relevant to HIMSS members.
Health and technology innovators are studying astronauts' health to advance terrestrial healthcare. James Hury, deputy director and chief innovation officer at the Translational Research Institute for Space Health, explains how.
With pharmacogenomics now common in primary care, and an array of specialties using genetics, Dr. Joel Diamond of 2bPrecise says precision medicine is ready for prime time.
Dr. Maulik Purohit, clinical innovation lead for transformation at University Hospitals, discusses tech strategies, patient communication and the challenges of clinical genetics and population health genomics.
